RecruitingNCT04799535

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring


Sponsor

Mayo Clinic

Enrollment

550 participants

Start Date

Sep 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new type of ultrasound imaging that can measure tiny blood vessels in breast tissue, to see if it can more accurately detect breast cancer and track how well chemotherapy is working — potentially reducing the need for more invasive procedures. **You may be eligible if...** - You are 18 or older with a suspicious breast lump scheduled for biopsy, OR who recently had a biopsy - OR you have been diagnosed with breast cancer and are receiving chemotherapy before surgery - OR you have finished all breast cancer treatment **You may NOT be eligible if...** - You are unable to undergo the imaging procedure - You do not meet the specific criteria for the study group you would join Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUltrasound

Undergo breast ultrasound


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04799535


Related Trials